Cargando…

Predicting Treatment Response in Inflammatory Bowel Diseases: Cross-Sectional Imaging Markers

Therapeutic options for inflammatory bowel diseases (IBD) have largely expanded in the last decades, both in Crohn’s disease and ulcerative colitis, including multiple biological drugs targeting different inflammation pathways. However, choosing the best treatment and timing for each patient is stil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mignini, Irene, Maresca, Rossella, Ainora, Maria Elena, Larosa, Luigi, Scaldaferri, Franco, Gasbarrini, Antonio, Zocco, Maria Assunta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532020/ https://www.ncbi.nlm.nih.gov/pubmed/37762874 http://dx.doi.org/10.3390/jcm12185933

Ejemplares similares

Tumorigenesis in Inflammatory Bowel Disease: Microbiota-Environment Interconnections
por: Mignini, Irene, et al.
Publicado: (2023)

Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: The Prognostic Role of Liver Stiffness Measurement
por: Cerrito, Lucia, et al.
Publicado: (2023)

Role of Multiparametric Intestinal Ultrasound in the Evaluation of Response to Biologic Therapy in Adults with Crohn’s Disease
por: Puca, Pierluigi, et al.
Publicado: (2022)

Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy
por: Cerrito, Lucia, et al.
Publicado: (2022)

Dynamic contrast enhanced ultrasound in gastrointestinal diseases: A current trend or an indispensable tool?
por: Paratore, Mattia, et al.
Publicado: (2023)

Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors
por: Ainora, Maria Elena, et al.
Publicado: (2023)

The Role of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Neoplastic Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma
por: Cerrito, Lucia, et al.
Publicado: (2023)

Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma
por: Faccia, Mariella, et al.
Publicado: (2022)

Shear Wave Dispersion in Chronic Liver Disease: From Physical Principles to Clinical Usefulness
por: Garcovich, Matteo, et al.
Publicado: (2023)

Ultrasound Elastography to Assess Age of Deep Vein Thrombosis: A Systematic Review
por: Santini, Paolo, et al.
Publicado: (2023)

Elastography as a predictor of liver cirrhosis complications after hepatitis C virus eradication in the era of direct-acting antivirals
por: Cerrito, Lucia, et al.
Publicado: (2021)

Correlation between a New Point-Shear Wave Elastography Device (X+pSWE) with Liver Histology and 2D-SWE (SSI) for Liver Stiffness Quantification in Chronic Liver Disease
por: Garcovich, Matteo, et al.
Publicado: (2023)

Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate
por: Faccia, Mariella, et al.
Publicado: (2019)

Endoscopic Ultrasound-Guided Locoregional Treatments for Solid Pancreatic Neoplasms
por: Di Gialleonardo, Luca, et al.
Publicado: (2023)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014)

Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives
por: Cerrito, Lucia, et al.
Publicado: (2023)

The Role of Transabdominal Ultrasound Elastography in Gastrointestinal Non-Liver Diseases: Current Application and Future Prospectives
por: Paratore, Mattia, et al.
Publicado: (2023)

Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives
por: Nicoletti, Alberto, et al.
Publicado: (2023)

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study
por: Ponziani, Francesca Romana, et al.
Publicado: (2019)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies
por: Di Vincenzo, Federica, et al.
Publicado: (2023)

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
por: Papa, Alfredo, et al.
Publicado: (2022)

MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer
por: Masi, Letizia, et al.
Publicado: (2022)

Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
por: Baldelli, Valerio, et al.
Publicado: (2021)

Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
por: Faccia, Mariella, et al.
Publicado: (2022)

Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

The Role of Nutrition in the COVID-19 Pandemic
por: Mentella, Maria Chiara, et al.
Publicado: (2021)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure
por: Nardone, Olga Maria, et al.
Publicado: (2021)

Commensal Clostridia: leading players in the maintenance of gut homeostasis
por: Lopetuso, Loris R, et al.
Publicado: (2013)

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
por: Scaldaferri, Franco, et al.
Publicado: (2020)

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy
por: Ojetti, Veronica, et al.
Publicado: (2012)

The Association of Disease Activity, BMI and Phase Angle with Vitamin D Deficiency in Patients with IBD
por: Mentella, Maria Chiara, et al.
Publicado: (2019)

Cancer and Mediterranean Diet: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2019)

Nutrition, IBD and Gut Microbiota: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vosdsokujagpkqu7lmnfhpof0q